Our Research Team


Steven Belinsky, PhD

Vice President for Research/Professor

Carmen Tellez, PhD

Senior Research Scientist

Guodong Wu, PhD

Research Scientist/ Senior Statistician

Adriana E. Kajon, PhD

Professor

Janet Benson, PhD

Scientist Emeritus

Mathewos Tessema, PhD

Associate Professor

Dan Covey, PhD

Assistant Professor

Andrew R. Mayer, PhD

Vice-President of Interdisciplinary Science

Director of Trauma and En Route Care Programs

Jon M. Houck, PhD

Research Assistant, Associate Professor

Steven Baker, PhD

Assistant Professor

Rachel Cooper, DVM, MS, DACLAM

Attending Veterinarian

Shuguang Leng, MBBS PhD

Fellow/Assistant Professor
John T. Farmer, Ph.D.  Director Immunology & Large Molecule Bioanalysis

John Farmer, PhD

Director of Immunology & Large Molecule Bioanalytical Chemistry
David Revelli

David Revelli, PhD

Director ABSL-3/Research Scientist
Danielle Adney, DVM, PhD

Daniela Schwotzer

Associate Research Scientist/Study Director
Conor A. Ruzycki, PhD

Conor A. Ruzycki, PhD

Associate Research Scientist

The Mind Research Network

We partner with clients across many distinct sectors, applying our knowledge and expertise and specialized facilities and equipment to each project. Our successful partnerships include those with government agencies, commercial entities, trade associations, and academic institutions. Lovelace regularly forms partnerships working for and with many academic institutions.

Mental Health and Neuroscience research are performed within our Mind Research Network (MRN) division. MRN has a vast breadth and depth of neuroimaging expertise covering everything from premature infants to aging disorders and everything in between – schizophrenia/mental illness, forensics, moral judgement, recidivism, traumatic brain injury (pediatric, adult and war/blast induced), addiction (tobacco, alcohol and drug use), as well as incidental findings and research ethics. New expansion into basic research is studying mechanisms and developing biomarkers around traumatic brain injury and dopamine neurotransmission in drug addiction. MRN state-of-the-art magnetic resonance imaging (MRI) and magnetoencephalogram (MEG) neuroimaging systems to be applied to mental illness research in collaboration with other top research centers in the US. Further, the mission includes the evaluation of tools to develop a more fundamental and systematic understanding of the human brain.

The infectious disease program takes advantage of expansive B3 facilities for conducting in vitro and in vivo studies with highly pathogenic viruses such as SARS-COV-2 and to allow testing of novel therapies and vaccines. Basic research is focused on understanding the molecular epidemiology and pathogenesis of human acute respiratory infection at the cellular and population level and the use of small animal models for studying pathogenesis. In addition, a rich history of studying influenza viruses continues with activity toward understanding how host-specific differential alternative RNA-splicing impacts virus evolution along with defining factors underlying innate immunity, adaptive immune protection, and adaption.